Capecitabine 55111-0496
Product NDC
55111-0496- Manufacturer
- Dr. Reddy's Laboratories Limited
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- December 10, 2020
- Listing Expires
- December 31, 2027
- Application
- ANDA204345
Need to source Capecitabine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Capecitabine | 150 mg/1 |
Drug Class
Nucleoside Metabolic Inhibitor [EPC]Nucleic Acid Synthesis Inhibitors [MoA]Nucleoside Metabolic Inhibitor [EPC]
Packaging Options(2)
500 TABLET in 1 BOTTLE (55111-496-05)
60 TABLET in 1 BOTTLE (55111-496-60)